Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Can Hyperlume help Credo Technology outpace rivals in the race for AI infrastructure? Credo Technology (NASDAQ: CRDO) acquires Hyperlume to add microLED optical interconnects, boosting its position in AI-era high-speed connectivity markets. byPallavi MadhirajuSeptember 30, 2025